AIM 8-K: SEC filing
Filed with the SEC on · accession 0001493152-26-053005
AIM filed a 8-K (current report) with the SEC on Nov 18, 2026. AIM ImmunoTech adjourned its 2026 Annual Meeting of Stockholders because it lacked a quorum, and will reconvene the meeting virtually on December 8, 2026.
Summary of the filing
AIM ImmunoTech adjourned its 2026 Annual Meeting of Stockholders because it lacked a quorum, and will reconvene the meeting virtually on December 8, 2026. No changes were made to the proposals to be voted on.
Key details
✦ Ask GOAX AI about this filing — what it means for AIM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AIM?
Click hereFrequently asked questions
What did AIM file with the SEC on Nov 18, 2026?
AIM filed a 8-K (SEC filing). AIM ImmunoTech adjourned its 2026 Annual Meeting of Stockholders because it lacked a quorum, and will reconvene the meeting virtually on December 8, 2026. No changes were made to the proposals to be voted on.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other AIM SEC filings
Get alerts when AIM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days